| Reference | Name | Unity | Provider | Aplication | Clonality | Host | Reactivity | Price | Tech.Sheet |
|---|---|---|---|---|---|---|---|---|---|
| Ab04206-23.0 | Anti-p150glued [S11E] | 100 ug | Absolute Antibody | WB; IF | Human | Request Quotation | Request | ||
| Ab03050-2.3-BT | Anti-CD4 [OX-38] | 1 mg | Absolute Antibody | FC; IP | Rat | Request Quotation | Request | ||
| Ab04210-2.0-BT | Anti-Collagenase type IV [3G11] | 1 mg | Absolute Antibody | ELISA; Immunoscintigraphy; MTT assay; IHC; IF; in | Mouse | Request Quotation | Request | ||
| Ab01988-10.29-BS | Anti-ZSCAN5C [RAB-S178] | 1 mg | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab00730-10.6 | Anti-CD33 [SGN-33 (Lintuzumab)] | 200 ug | Absolute Antibody | functional | Human | Request Quotation | Request | ||
| Ab01987-1.29-BS | Anti-ZSCAN5B [RAB-S167] | 1 mg | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab04215-2.0-BT | Anti-CXCL12 [30D8] | 1 mg | Absolute Antibody | ELISA; Blocking; in vitro; in vivo; BLI; Crystalli | Mouse; Human; Rat; Cynomolgus Monkey | Request Quotation | Request | ||
| Ab01989-1.29-BT | Anti-ZSCAN9 [RAB-C493] | 500 ug | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab03690-10.3-BT | Anti-Chronic lymphocytic leukemia [Lym-2] | 1 mg | Absolute Antibody | IF; FC; IHC; in vitro; in vivo; therapeutic | Human | Request Quotation | Request | ||
| Ab04215-23.0-BT | Anti-CXCL12 [30D8] | 1 mg | Absolute Antibody | ELISA; Blocking; in vitro; in vivo; BLI; Crystalli | Mouse; Human; Rat; Cynomolgus Monkey | Request Quotation | Request | ||
| Ab03007-1.29-BT | Anti-Rabbit IgG [A10B] | 500 ug | Absolute Antibody | ELISA; WB; SPR | Rabbit | Request Quotation | Request | ||
| Ab01989-1.29-BS | Anti-ZSCAN9 [RAB-C493] | 1 mg | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab04212-23.0-BT | Anti-CD81 [Ab10] | 1 mg | Absolute Antibody | FACS; Inhibition; Crystallization; FC | Human | Request Quotation | Request | ||
| Ab03743-10.3 | Anti-CD42a [ESS] | 100 ug | Absolute Antibody | FC | Human | Request Quotation | Request | ||
| Ab04209-23.0 | Anti-Non muscle Myosin IIA [SF9] | 100 ug | Absolute Antibody | WB; IF | Human; Rat; Drosophila | Request Quotation | Request | ||
| Ab04206-10.0 | Anti-p150glued [S11E] | 100 ug | Absolute Antibody | WB; IF | Human | Request Quotation | Request | ||
| Ab01206-10.3-BT | Anti-MOG [M3-8] | 1 mg | Absolute Antibody | ELISA; blocking; IHC | Rat | Request Quotation | Request | ||
| Ab04218-10.0 | Anti-PADI4 [197-A5] | 100 ug | Absolute Antibody | ELISA; WB | Human | Request Quotation | Request | ||
| bAb0338 | Anti-Spike protein (RBD) [Sb#15] | 50 ug | Absolute Antibody | ELISA; inhibition; grating-coupled interferometry; | SARS Coronavirus 2 (SARS-Cov-2) | Request Quotation | Request | ||
| Ab00730-10.3 | Anti-CD33 [SGN-33 (Lintuzumab)] | 200 ug | Absolute Antibody | functional | Human | Request Quotation | Request | ||
| Ab03743-10.3-BT | Anti-CD42a [ESS] | 1 mg | Absolute Antibody | FC | Human | Request Quotation | Request | ||
| Ab04212-23.0 | Anti-CD81 [Ab10] | 100 ug | Absolute Antibody | FACS; Inhibition; Crystallization; FC | Human | Request Quotation | Request | ||
| Ab04205-30.11-BT | Anti-?-tubulin [S11B] | 500 ug | Absolute Antibody | WB; IF | Human | Request Quotation | Request | ||
| Ab04212-1.1 | Anti-CD81 [Ab10] | 100 ug | Absolute Antibody | FACS; Inhibition; Crystallization; FC | Human | Request Quotation | Request | ||
| Ab04211-23.0 | Anti-Tenuazonic acid (TeA) [3F9] | 100 ug | Absolute Antibody | ELISA; ic-ELISA; chemiluminescent enzyme immunoass | Other | Request Quotation | Request | ||
| Ab03926-30.11-BT | Anti-17-1A [VD4.5VK8] | 500 ug | Absolute Antibody | ELISA | Human | Request Quotation | Request | ||
| Ab00114-10.3-BT | Anti-HLA Class 1 [W6/32] | 1 mg | Absolute Antibody | FC; ELISA; IF; IP; IHC | Human | Request Quotation | Request | ||
| Ab04215-23.0 | Anti-CXCL12 [30D8] | 100 ug | Absolute Antibody | ELISA; Blocking; in vitro; in vivo; BLI; Crystalli | Mouse; Human; Rat; Cynomolgus Monkey | Request Quotation | Request | ||
| Ab03050-2.3 | Anti-CD4 [OX-38] | 100 ug | Absolute Antibody | FC; IP | Rat | Request Quotation | Request | ||
| Ab02866-2.3-BT | Anti-Mojiang Virus G [2B2-LY*] | 1 mg | Absolute Antibody | FC; IP; ELISA | Mòji?ng virus | Request Quotation | Request | ||
| Ab01989-10.29-BT | Anti-ZSCAN9 [RAB-C493] | 500 ug | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab04213-23.0-BT | Anti-paraoxon (organophosphate) [A.17 L47K] | 1 mg | Absolute Antibody | Catalyzation; Crystallization | Other | Request Quotation | Request | ||
| Ab00693-10.6-BT | Anti-CD5 [UCHT2] | 500 ug | Absolute Antibody | FC; IHC; WB | Human | Request Quotation | Request | ||
| Ab01987-1.29-BT | Anti-ZSCAN5B [RAB-S167] | 500 ug | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| bAb0338-BT | Anti-Spike protein (RBD) [Sb#15] | 500 ug | Absolute Antibody | ELISA; inhibition; grating-coupled interferometry; | SARS Coronavirus 2 (SARS-Cov-2) | Request Quotation | Request | ||
| Ab04205-10.3-BT | Anti-?-tubulin [S11B] | 1 mg | Absolute Antibody | WB; IF | Human | Request Quotation | Request | ||
| Ab04218-23.0 | Anti-PADI4 [197-A5] | 100 ug | Absolute Antibody | ELISA; WB | Human | Request Quotation | Request |